Published On: November 3rd, 2010
It’s not yet clear whether generic versions of large-molecule biologic drugs will have to undergo separate trials.

More:
Medco, Amgen Weigh in On Biosimilars at FDA Meeting
STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.
Loading...
Did you know:
Colorectal: 47.4 per 100,000 people per year
-
BreakingBBnews : Cyclists ride North Shore for good times: Two days after pro cyclists raced along the North Shore in the Amgen Tour... http://t.co/yuafeoJR2012-05-23T14:03:02Z - Reply - View Tweet
-
t8ph : RT @wired_jp: ??????????????????????????????2012????????? ???????????????????????????????????????????? http://t.co/aOx5Y3Sm #wired_jp2012-05-23T13:58:52Z - Reply - View Tweet
-
bokuo_okubo_ : RT @wired_jp: ??????????????????????????????2012????????? ???????????????????????????????????????????? http://t.co/aOx5Y3Sm #wired_jp2012-05-23T13:46:12Z - Reply - View Tweet
-
DigitalPirates : ????? RT @wired_jp: ??????????????????????????????2012????????? ???????????????????????????????????????????? http://t.co/Lpn8KyQv #wired_jp2012-05-23T13:44:45Z - Reply - View Tweet
-
shun_r265 : RT @wired_jp: ??????????????????????????????2012????????? ???????????????????????????????????????????? http://t.co/aOx5Y3Sm #wired_jp2012-05-23T13:43:43Z - Reply - View Tweet
-
pyonnkiti_ks : ????????????????????????2012????????? http://t.co/dXOGYQxj2012-05-23T13:37:35Z - Reply - View Tweet
-
linsbar : ??????RT @wired_jp:????????????????????????2012????????? ???????????????????????????????????????? http://t.co/KCbk66VO #wired_jp2012-05-23T13:36:20Z - Reply - View Tweet
Related Posts
- New Blood Thinners in the Spotlight at Heart Meeting
The annual European Society of Cardiology meeting begins this weekend in Barcelona, and here are three key late-stage trials on different anti-clotting agents from big drug makers that are headlining the session: 1) RE-LY: This large study examined the safety and efficacy of Boehringer Ingelheim’s investigational anti-clotting therapy, Prodaxa, against the current gold standard, warfarin,.. - Devices and Drugs in Focus at Big Cardiologists Meeting
By Anjali Athavaley and Peter Loftus One of the biggest heart-medicine events of the year kicks off Saturday in Chicago. Updates on new devices, drugs and techniques will be discussed during hundreds of sessions at the American College of Cardiology’s annual conference, which runs through Tuesday. .. - XMRV On Everyone’s Mind at a Chronic Fatigue Syndrome Meeting
At the meeting’s public comment period, CFS patients pressed for more funding to study XMRV and to launch clinical trials. .. - Medical Societies Weigh in on Permanent Fix to Medicare Reimbursement
At a House subcommittee meeting today, medical societies weighed in on how to fix the much-maligned Medicare physician payment formula. The current formula, which absolutely no one thinks can continue in its present form, is (ironically) called the Sustainable Growth Rate, or SGR. It pegs the growth of Medicare reimbursement to the GDP — problematic,.. - A.M. Vitals: A New Wave of Multiple Sclerosis Medicines — in Pill Form
Controlling MS: Drugs taken orally to control multiple sclerosis are beginning to hit the market, starting with Novartis’s Gilenya, but while they’re attractive to patients, the price is high and the extent of side effects unknown, the WSJ reports . Gilenya costs about $48,000 a year, compared to about $40,000 for currently available injectable drugs... - Cervical Cancer Vaccine: A Death in U.K., Delay at FDA
A British schoolgirl died yesterday, a few hours after getting a shot of a vaccine designed to prevent cervical cancer. ..
Leave a comment









